$GMED SEC Filings

Filed On	Filing
27 Oct 2026	SCHEDULE 13G/A
16 Sep 2026	Form 4: Tobin James R, Director Received 30,000 shares by exercise or conversion ($1.76M) · Sold 30,000 shares ($2.24M)
15 Sep 2026	144
19 Aug 2026	Form 4: Zarrilli Stephen T, Director Received 25,000 shares by exercise or conversion ($1.33M) · Sold 25,000 shares ($2.18M)
18 Aug 2026	144
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	Form 4: Davidar David D, Director Gave 2,500 shares as a gift
09 Jun 2026	Form 4: Davidar David D, Director Received 25,000 shares by exercise or conversion ($657K) · Sold 25,000 shares ($2.02M)
08 Jun 2026	Form 4: Rhoads Ann D, Director Received 25,000 shares by exercise or conversion ($657K)
05 Jun 2026	144
04 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
27 May 2026	SD
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition
30 Apr 2026	SCHEDULE 13G
24 Apr 2026	DEFA14A
24 Apr 2026	Proxy statement: annual meeting on June 3, 2026 CEO pay $4.4M, up 86% · say-on-pay vote
14 Apr 2026	144
26 Mar 2026	SCHEDULE 13G/A

Comments